Real-world multicenter outcomes of CD3xCD20 bispecific antibody therapies in patients with central nervous system (CNS) lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417005146
Cites:
Cited by:
Related to:
